Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 709

1.

A prospective pilot study of the T-lymphocyte response to fine particulate matter exposure.

Al Zallouha M, Landkocz Y, Méausoone C, Ledoux F, Visade F, Cazier F, Martin PJ, Borgie M, Vitagliano JJ, Trémolet G, Cailliez JC, Gosset P, Courcot D, Billet S.

J Appl Toxicol. 2020 Jan 23. doi: 10.1002/jat.3932. [Epub ahead of print]

PMID:
31975422
2.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, Hingorani S, Boeckh M, Flowers MD, Lee SJ, Appelbaum FR, Storb R, Martin PJ, Deeg HJ, Schoch G, Gooley TA.

Ann Intern Med. 2020 Jan 21. doi: 10.7326/M19-2936. [Epub ahead of print]

PMID:
31958813
3.

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA.

Blood Adv. 2020 Jan 14;4(1):40-46. doi: 10.1182/bloodadvances.2019000918.

4.

Disability Related to Chronic Graft-versus-Host Disease.

Hamilton BK, Storer BE, Wood WA, Pidala JA, Cutler CS, Martin PJ, Chen G, Flowers ME, Lee SJ.

Biol Blood Marrow Transplant. 2019 Oct 24. pii: S1083-8791(19)30676-7. doi: 10.1016/j.bbmt.2019.10.019. [Epub ahead of print]

PMID:
31669175
5.

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.

Inamoto Y, White J, Ito R, Martin PJ, Fatobene G, Ito A, Tanaka T, Kurosawa S, Kim SW, Bar M, Sorror ML, Sandmaier BM, Lee SJ, Fukuda T, Flowers MED.

Blood Adv. 2019 Sep 24;3(18):2764-2777. doi: 10.1182/bloodadvances.2019000386.

6.

In Memoriam: John A. Hansen (1943-2019).

Martin PJ, Petersdorf EW.

HLA. 2019 Nov;94(5):405-406. doi: 10.1111/tan.13674. Epub 2019 Sep 10. No abstract available.

PMID:
31507090
7.

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.

Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, Waller EK, Burke E, Skerrett D, Shpall E, Martin PJ.

Biol Blood Marrow Transplant. 2019 Sep 7. pii: S1083-8791(19)30573-7. doi: 10.1016/j.bbmt.2019.08.029. [Epub ahead of print]

PMID:
31505228
8.

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Pidala JA, Hamilton BK, Martin PJ, Onstad L, Storer BE, Palmer J, Alousi A, Cutler C, Jagasia MH, Chen GL, Arora M, Flowers ME, Lee SJ.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2468-2473. doi: 10.1016/j.bbmt.2019.07.040. Epub 2019 Aug 5.

PMID:
31394265
9.

Cellular response and extracellular vesicles characterization of human macrophages exposed to fine atmospheric particulate matter.

Martin PJ, Héliot A, Trémolet G, Landkocz Y, Dewaele D, Cazier F, Ledoux F, Courcot D.

Environ Pollut. 2019 Nov;254(Pt A):112933. doi: 10.1016/j.envpol.2019.07.101. Epub 2019 Jul 25.

PMID:
31382213
10.

Photodissociation of S2 (X3Σg-, a1Δg, and b1Σg+) in the 320-205 nm Region.

Sun ZF, Farooq Z, Parker DH, Martin PJJ, Western CM.

J Phys Chem A. 2019 Aug 15;123(32):6886-6896. doi: 10.1021/acs.jpca.9b05350. Epub 2019 Aug 2.

11.

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

Sandmaier BM, Kornblit B, Storer BE, Olesen G, Maris MB, Langston AA, Gutman JA, Petersen SL, Chauncey TR, Bethge WA, Pulsipher MA, Woolfrey AE, Mielcarek M, Martin PJ, Appelbaum FR, Flowers MED, Maloney DG, Storb R.

Lancet Haematol. 2019 Aug;6(8):e409-e418. doi: 10.1016/S2352-3026(19)30088-2. Epub 2019 Jun 24.

PMID:
31248843
12.

Modelling the Temperature Dependent Biaxial Response of Poly(ether-ether-ketone) Above and Below the Glass Transition for Thermoforming Applications.

Turner JA, Menary GH, Martin PJ, Yan S.

Polymers (Basel). 2019 Jun 12;11(6). pii: E1042. doi: 10.3390/polym11061042.

13.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

Martin PJ, Storer BE, Palmer J, Jagasia MH, Chen GL, Broady R, Arora M, Pidala JA, Hamilton BK, Lee SJ.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1869-1874. doi: 10.1016/j.bbmt.2019.05.008. Epub 2019 May 11.

PMID:
31085305
14.

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

McCune JS, Wang T, Bo-Subait K, Aljurf M, Beitinjaneh A, Bubalo J, Cahn JY, Cerny J, Chhabra S, Cumpston A, Dupuis LL, Lazarus HM, Marks DI, Maziarz RT, Norkin M, Prestidge T, Mineishi S, Krem MM, Pasquini M, Martin PJ.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1424-1431. doi: 10.1016/j.bbmt.2019.03.001. Epub 2019 Mar 11.

PMID:
30871976
15.

Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80.

Cassady K, Martin PJ, Zeng D.

Front Immunol. 2018 Dec 21;9:3061. doi: 10.3389/fimmu.2018.03061. eCollection 2018. Review.

16.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

Rozmus J, Kariminia A, Abdossamadi S, Storer BE, Martin PJ, Lee SJ, Wolff D, Arora M, Cutler C, Schultz KR.

Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14.

PMID:
30447393
17.

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation.

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, Carpenter PA, Balgansuren G, Petersdorf EW, Delaney C, Sandmaier BM, Milano F, Flowers ME.

Haematologica. 2019 Apr;104(4):835-843. doi: 10.3324/haematol.2018.202754. Epub 2018 Nov 15.

18.

Chemical characterization of fine and ultrafine PM, direct and indirect genotoxicity of PM and their organic extracts on pulmonary cells.

Billet S, Landkocz Y, Martin PJ, Verdin A, Ledoux F, Lepers C, André V, Cazier F, Sichel F, Shirali P, Gosset P, Courcot D.

J Environ Sci (China). 2018 Sep;71:168-178. doi: 10.1016/j.jes.2018.04.022. Epub 2018 Apr 27.

PMID:
30195675
19.

Influence of aging in the modulation of epigenetic biomarkers of carcinogenesis after exposure to air pollution.

Fougère B, Landkocz Y, Lepers C, Martin PJ, Armand L, Grossin N, Verdin A, Boulanger E, Gosset P, Sichel F, Shirali P, Billet S.

Exp Gerontol. 2018 Sep;110:125-132. doi: 10.1016/j.exger.2018.05.018. Epub 2018 May 31.

PMID:
29860068
20.

Biomineralization of osteoblasts on DLC coated surfaces for bone implants.

B S, S TR, Martin PJ, Vaithilingam V, Bean PA, Evans MDM, Bendavid A.

Biointerphases. 2018 May 22;13(4):041002. doi: 10.1116/1.5007805.

PMID:
29788723
21.

Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.

Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, Romano E, Romano JM, Martin PJ, Yi JC.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1692-1698. doi: 10.1016/j.bbmt.2018.05.004. Epub 2018 May 9.

22.

An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation.

Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM.

J Cancer Surviv. 2018 Aug;12(4):560-570. doi: 10.1007/s11764-018-0693-9. Epub 2018 May 5.

23.

Pathogenic neutrophils in acute GVHD.

Martin PJ.

Blood. 2018 Apr 19;131(16):1774-1775. doi: 10.1182/blood-2018-03-836353. No abstract available.

PMID:
29674354
24.

Tuning the plasmonic response of TiN nanoparticles synthesised by the transferred arc plasma technique.

Yick S, Murdock AT, Martin PJ, Kennedy DF, Maschmeyer T, Bendavid A.

Nanoscale. 2018 Apr 26;10(16):7566-7574. doi: 10.1039/c7nr09309h.

PMID:
29637963
25.

Groundwater Modeling with Nonlinear Uncertainty Analyses to Enhance Remediation Design Confidence.

Brouwers M, Martin PJ, Abbey DG, White J.

Ground Water. 2018 Jul;56(4):562-570. doi: 10.1111/gwat.12669. Epub 2018 Apr 25.

PMID:
29633236
26.

Cytocompatible tantalum films on Ti6Al4V substrate by filtered cathodic vacuum arc deposition.

Hee AC, Cao H, Zhao Y, Jamali SS, Bendavid A, Martin PJ.

Bioelectrochemistry. 2018 Aug;122:32-39. doi: 10.1016/j.bioelechem.2018.02.006. Epub 2018 Feb 27.

PMID:
29518622
27.

Bortezomib for prevention of acute graft-versus-host disease: a conclusion reached.

Martin PJ.

Haematologica. 2018 Mar;103(3):377-379. doi: 10.3324/haematol.2018.188052. No abstract available.

28.

Obligation for transparency regarding treating physician credentials at academic health centres.

Martin PJ, Skill NJ, Koniaris LG.

J Med Ethics. 2018 Nov;44(11):782-786. doi: 10.1136/medethics-2016-103937. Epub 2018 Feb 26.

PMID:
29483234
29.

Educating Radiologists for Self-governance.

Gunderman RB, Martin PJ.

Acad Radiol. 2018 Apr;25(4):540-542. doi: 10.1016/j.acra.2017.12.017. Epub 2018 Feb 7. No abstract available.

PMID:
29395800
30.

Comparative study of diesel and biodiesel exhausts on lung oxidative stress and genotoxicity in rats.

Douki T, Corbière C, Preterre D, Martin PJ, Lecureur V, André V, Landkocz Y, Pottier I, Keravec V, Fardel O, Moreira-Rebelo S, Pottier D, Vendeville C, Dionnet F, Gosset P, Billet S, Monteil C, Sichel F.

Environ Pollut. 2018 Apr;235:514-524. doi: 10.1016/j.envpol.2017.12.077. Epub 2018 Jan 8.

PMID:
29324381
31.

Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Leger KJ, Baker KS, Cushing-Haugen KL, Flowers MED, Leisenring WM, Martin PJ, Mendoza JA, Reding KW, Syrjala KL, Lee SJ, Chow EJ.

Cancer. 2018 Apr 1;124(7):1507-1515. doi: 10.1002/cncr.31227. Epub 2018 Jan 9.

32.

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma.

Green DJ, Maloney DG, Storer BE, Sandmaier BM, Holmberg LA, Becker PS, Fang M, Martin PJ, Georges GE, Bouvier ME, Storb R, Mielcarek M.

Blood Adv. 2017 Nov 9;1(24):2247-2256. doi: 10.1182/bloodadvances.2017010686. eCollection 2017 Nov 14.

33.

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.

Lee SJ, Nguyen TD, Onstad L, Bar M, Krakow EF, Salit RB, Carpenter PA, Rodrigues M, Hall AM, Storer BE, Martin PJ, Flowers ME.

Biol Blood Marrow Transplant. 2018 Mar;24(3):555-562. doi: 10.1016/j.bbmt.2017.10.042. Epub 2017 Nov 10.

34.

Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.

Deng R, Hurtz C, Song Q, Yue C, Xiao G, Yu H, Wu X, Muschen M, Forman S, Martin PJ, Zeng D.

Nat Commun. 2017 Oct 17;8(1):978. doi: 10.1038/s41467-017-00880-2.

35.

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB.

J Clin Oncol. 2017 Dec 20;35(36):4003-4011. doi: 10.1200/JCO.2017.75.8177. Epub 2017 Oct 17.

PMID:
29040031
36.

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

Hamilton BK, Rybicki L, Arai S, Arora M, Cutler CS, Flowers MED, Jagasia M, Martin PJ, Palmer J, Pidala J, Majhail NS, Lee SJ, Khera N.

Biol Blood Marrow Transplant. 2018 Feb;24(2):393-399. doi: 10.1016/j.bbmt.2017.10.009. Epub 2017 Oct 12.

37.

Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease.

Steinbach G, Hockenbery DM, Huls G, Furlong T, Myerson D, Loeb KR, Fann JR, Castilla-Llorente C, McDonald GB, Martin PJ.

PLoS One. 2017 Aug 17;12(8):e0183284. doi: 10.1371/journal.pone.0183284. eCollection 2017.

38.

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.

Carpenter PA, Johnston L, Fernandez HF, Radich JP, Mauro MJ, Flowers MED, Martin PJ, Gooley TA.

Blood. 2017 Aug 31;130(9):1170-1172. doi: 10.1182/blood-2017-03-771121. Epub 2017 Jul 11. No abstract available.

PMID:
28698203
39.

Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma.

Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA.

Clin Cancer Res. 2017 Oct 1;23(19):5696-5702. doi: 10.1158/1078-0432.CCR-16-3232. Epub 2017 Jul 5.

40.

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.

Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, Palmer J, Arora M, Jagasia M, Arai S, Cutler CS, Lee SJ.

Blood. 2017 Jul 20;130(3):360-367. doi: 10.1182/blood-2017-03-775767. Epub 2017 May 11.

41.

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

McDonald GB, Tabellini L, Storer BE, Martin PJ, Lawler RL, Rosinski SL, Schoch HG, Hansen JA.

Biol Blood Marrow Transplant. 2017 Aug;23(8):1257-1263. doi: 10.1016/j.bbmt.2017.04.029. Epub 2017 May 3.

42.

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, Flowers MED, Lee SJ, Carpenter PA, Storer BE, Hanash S, Hansen JA.

Biol Blood Marrow Transplant. 2017 Aug;23(8):1250-1256. doi: 10.1016/j.bbmt.2017.04.019. Epub 2017 Apr 25.

43.

PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.

Ni X, Song Q, Cassady K, Deng R, Jin H, Zhang M, Dong H, Forman S, Martin PJ, Chen YZ, Wang J, Zeng D.

J Clin Invest. 2017 May 1;127(5):1960-1977. doi: 10.1172/JCI91138. Epub 2017 Apr 17.

44.

Biomineralisation with Saos-2 bone cells on TiSiN sputtered Ti alloys.

V V AT, Bendavid A, Martin PJ, Vaithilingam V, Bean PA, Evans MDM, Subramanian B.

Colloids Surf B Biointerfaces. 2017 Jul 1;155:1-10. doi: 10.1016/j.colsurfb.2017.03.039. Epub 2017 Mar 18.

PMID:
28384526
45.

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation.

Fisher CE, Hohl TM, Fan W, Storer BE, Levine DM, Zhao LP, Martin PJ, Warren EH, Boeckh M, Hansen JA.

Blood. 2017 May 11;129(19):2693-2701. doi: 10.1182/blood-2016-10-743294. Epub 2017 Mar 7.

46.

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis.

Pidala J, Sigdel TK, Wang A, Hsieh S, Inamoto Y, Martin PJ, Flowers ME, Hansen JA, Lee SJ, Sarwal MM.

J Pathol Clin Res. 2016 Nov 29;3(1):3-16. doi: 10.1002/cjp2.58. eCollection 2017 Jan.

47.

Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.

Parsons JE, Lau MPH, Martin PJ, Islas Lagos JJ, Aguilar Aguirre JM, Garza Leal JG.

J Minim Invasive Gynecol. 2017 May - Jun;24(4):579-591. doi: 10.1016/j.jmig.2017.01.010. Epub 2017 Jan 18.

PMID:
28109895
48.

Smoker extracellular vesicles influence status of human bronchial epithelial cells.

Héliot A, Landkocz Y, Roy Saint-Georges F, Gosset P, Billet S, Shirali P, Courcot D, Martin PJ.

Int J Hyg Environ Health. 2017 Apr;220(2 Pt B):445-454. doi: 10.1016/j.ijheh.2016.12.010. Epub 2016 Dec 30.

PMID:
28063900
49.

CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.

Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, Socie G, Anasetti C.

Biol Blood Marrow Transplant. 2017 Mar;23(3):405-411. doi: 10.1016/j.bbmt.2016.12.624. Epub 2016 Dec 19.

50.

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.

Watkins BK, Horan J, Storer B, Martin PJ, Carpenter PA, Flowers ME.

Bone Marrow Transplant. 2017 Apr;52(4):625-626. doi: 10.1038/bmt.2016.328. Epub 2016 Dec 19. No abstract available.

PMID:
27991888

Supplemental Content

Loading ...
Support Center